Rxo (RXO) Operating Leases (2021 - 2026)

Rxo (RXO) has reported Operating Leases for 6 consecutive years, with $182.0 million the latest figure, recorded in Q1 2026.

• Operating Leases for Q1 2026 came in at $182.0 million, down 9.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $182.0 million (down 9.45% YoY), and the FY2025 annual result was $191.0 million, down 35.47% from the prior year.
• Operating Leases was $182.0 million for Q1 2026 at Rxo, down from $191.0 million in the prior quarter.
• Over five years, Operating Leases peaked at $296.0 million in Q4 2024 and troughed at $109.0 million in Q1 2023.
• Average Operating Leases over 5 years is $171.7 million, with a median of $160.0 million recorded in 2024.
• Year-over-year, Operating Leases jumped 108.8% in 2024 and slumped 35.47% in 2025.
• Over 5 years, Operating Leases stood at $114.0 million in 2022, then grew by 28.07% to $146.0 million in 2023, then surged by 102.74% to $296.0 million in 2024, then plunged by 35.47% to $191.0 million in 2025, then retreated by 4.71% to $182.0 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $182.0 million in Q1 2026, $191.0 million in Q4 2025, and $202.0 million in Q3 2025.